Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.80    0.05 (2.86%)
Bid:
1.65
Ask:
1.80
Spread: 0.15 (9.091%)
Market Cap: £36.11m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Disposal

11 Sep 2009 07:00

RNS Number : 8892Y
Quintain Estates & Development PLC
11 September 2009
 



11 September 2009 

Quintain Estates & Development plc

("Quintain" / "Company" / "Group")

QUINTAIN REPATRIATES A FURTHER £31.3 MILLION OF CASH

Quintain announces the sale of units in The Quercus Healthcare Property Partnership ("Quercus" / the "Fund"for a total cash consideration of £31.3 million. The units have been sold to a number of UK institutional pension funds through the anonymous matched bargain dealing facility provided by Aviva Investors, Quintain's partner in the Fund.

This transaction was undertaken as part of Quintain's strategy to repatriate cash and reduce gearing, thereby enhancing the Company's financial flexibility. The proceeds of the disposal bring the total amount of cash repatriated since 1 April 2009 to over £42 million, representing 85% of the £50 million Quintain had targeted to raise in the year to 31 March 2010. The total cash repatriated by the Group since 1 April 2008 is now £140 million. 

Quercus is the largest fund within Quintain Fund Management. As at 30 June 2009, it had £759.9 million in funds under management and owned 264 assets, comprising nursing and residential care homes for the elderly, specialist care homes for those with long term disabilities, private hospitals, and care villages. The units were sold at a 12% discount to the Fund's reported NAV at July and a discount to Quintain's March valuation of £10.8mrepresenting a loss against book cost of £1.8 million. In the last twelve months, the units delivered £2.5 million of income to the Group

As a result of this disposalQuintain's total holding in Quercus is reduced from 25.4% to 16% and the number of investors in the Fund has increased to 50.

Rebecca Worthington, Finance Director of Quintain, commented: 

"This disposal represents another important milestone in our cash repatriation programme, taking the total raised to 85% of the £50 million we intend to repatriate by 31 March 2010 and thereby further enhancing Quintain's financial flexibility and control over interest costs."

For further information, please contact:

Quintain Estates & Development plc

Rebecca Worthington / Tonianne Dwyer / Cressida Curtis

Tel: +44 (0) 20 7495 8968

Financial Dynamics

Stephanie Highett / Dido Laurimore / Laurence Jones 

Tel: +44 (0) 20 7831 3113

Notes to Editors

Quintain Fund Management ("QFM") uses specialist property expertise to create value in its funds operating in three sectors with high barriers to entry: healthcare (Quercus), student accommodation (iQ) and science parks (Quantum). Each fund is underpinned by strong demographics such as an ageing population and increasing numbers of people entering higher education. The Funds interact with Quintain's other businesses, taking space on our major schemes, using the asset management skills within the Investment Portfolio and generating income that is used across the Group.

As at 31 March 2009, QFM's funds under management were £980 million.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISILFSRAIIILIA
Date   Source Headline
18th Feb 20137:00 amRNSHolding(s) in Company
14th Feb 20135:34 pmRNSHolding(s) in Company
13th Feb 201310:31 amRNSHolding(s) in Company
6th Feb 20137:00 amRNSThird Quarter Interim Management Statement
4th Feb 20134:04 pmRNSTotal Voting Rights
4th Feb 20133:59 pmRNSDirector/PDMR Shareholding
29th Jan 20134:05 pmRNSHolding(s) in Company
25th Jan 201310:15 amRNSHolding(s) in Company
24th Jan 201310:17 amRNSHolding(s) in Company
16th Jan 20134:25 pmRNSHolding(s) in Company
9th Jan 20133:08 pmRNSDirector/PDMR Shareholding
14th Dec 201210:24 amRNSHolding(s) in Company
3rd Dec 201211:46 amRNSTotal Voting Rights
3rd Dec 201211:18 amRNSBlocklisting Interim Review
3rd Dec 201210:39 amRNSDirector/PDMR Shareholding
26th Nov 201210:03 amRNSHolding(s) in Company
26th Nov 20127:00 amRNSResults for the six months ended 30 September 2012
13th Nov 201211:51 amRNSNotice of Results
6th Nov 201212:19 pmRNSAdditional Listing
1st Nov 20121:22 pmRNSTotal Voting Rights
1st Nov 20121:15 pmRNSDirector/PDMR Shareholding
31st Oct 20125:42 pmRNSHolding(s) in Company
31st Oct 20124:19 pmRNSHolding(s) in Company
31st Oct 20124:17 pmRNSHolding(s) in Company
4th Oct 201212:30 pmRNSHolding(s) in Company
1st Oct 201210:17 amRNSTotal Voting Rights
1st Oct 201210:14 amRNSDirector/PDMR Shareholding
25th Sep 20127:00 amRNSDirectorate Change
21st Sep 20128:37 amRNSHolding(s) in Company
11th Sep 20121:34 pmRNSDirector/PDMR Shareholding
31st Aug 20122:52 pmRNSTotal Voting Rights
31st Aug 20122:51 pmRNSDirector/PDMR Shareholding
8th Aug 20127:00 amRNSInterim Management Statement
24th Jul 20127:00 amRNSAppointment of new Finance Director
23rd Jul 20123:05 pmRNSResult of AGM
23rd Jul 20122:27 pmRNSEGM Statement
20th Jul 20125:29 pmRNSDirector/PDMR Shareholding
16th Jul 20123:00 pmRNSWembley Analyst and Investor presentation
13th Jul 20123:33 pmRNSDirector/PDMR Shareholding
4th Jul 20128:00 amRNSNew joint venture with Hong Kong investor
2nd Jul 20122:07 pmRNSAnnual Information Update
25th Jun 201212:34 pmRNSAnnual Financial Report
25th Jun 201210:41 amRNSDirector/PDMR Shareholding
20th Jun 20122:43 pmRNSHolding(s) in Company
19th Jun 20121:56 pmRNSDirector/PDMR Shareholding
18th Jun 20127:01 amRNSJoint Venture to develop Greenwich Peninsula
12th Jun 20122:27 pmRNSHolding(s) in Company
6th Jun 20121:34 pmRNSHolding(s) in Company
31st May 20124:11 pmRNSHolding(s) in Company
30th May 20121:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.